Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice
出版年份 2021 全文链接
标题
Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice
作者
关键词
Exosomes, Extracellular vesicles, PEGylation, Anti-PEG IgM, ABC phenomenon
出版物
JOURNAL OF CONTROLLED RELEASE
Volume 334, Issue -, Pages 327-334
出版商
Elsevier BV
发表日期
2021-05-04
DOI
10.1016/j.jconrel.2021.05.001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice
- (2020) Nehal E. Elsadek et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Hepatosplenic phagocytic cells indirectly contribute to anti-PEG IgM production in the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes: Appearance of an unexplained mechanism in the ABC phenomenon
- (2020) Marwa Mohamed El Sayed et al. JOURNAL OF CONTROLLED RELEASE
- Pegfilgrastim (PEG-G-CSF) Induces Anti-polyethylene Glycol (PEG) IgM via a T Cell-Dependent Mechanism
- (2020) Nehal E. Elsadek et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells
- (2019) María Sancho-Albero et al. JOURNAL OF NANOBIOTECHNOLOGY
- Surface Engineering of Extracellular Vesicles through Chemical and Biological Strategies
- (2019) Joseph J. Richardson et al. CHEMISTRY OF MATERIALS
- Toxicity and immunogenicity concerns related to PEGylated-micelle carrier systems: a review
- (2019) Kouichi Shiraishi et al. SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
- Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention
- (2019) Sixiang Shi et al. BIOCONJUGATE CHEMISTRY
- Generation, purification and engineering of extracellular vesicles and their biomedical applications
- (2019) Jin Gao et al. METHODS
- Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues
- (2019) Sherif E. Emam et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- T-Regulatory Cells In Tumor Progression And Therapy
- (2019) Amit Verma et al. Cancer Management and Research
- A Novel Strategy to Increase the Yield of Exosomes (Extracellular Vesicles) for an Expansion of Basic Research
- (2018) Sherif E. Emam et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Mesenchymal stromal cell exosome–enhanced regulatory T-cell production through an antigen-presenting cell–mediated pathway
- (2018) Bin Zhang et al. CYTOTHERAPY
- Exosomes as a Drug Delivery System in Cancer Therapy: Potential and Challenges
- (2018) Golam Kibria et al. MOLECULAR PHARMACEUTICS
- Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations
- (2018) Myung Soo Kim et al. Nanomedicine-Nanotechnology Biology and Medicine
- Exosomal lipid composition and the role of ether lipids and phosphoinositides in exosome biology
- (2018) Tore Skotland et al. JOURNAL OF LIPID RESEARCH
- Pharmacokinetics of Exosomes—An Important Factor for Elucidating the Biological Roles of Exosomes and for the Development of Exosome-Based Therapeutics
- (2017) Masaki Morishita et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
- (2016) Thomas J. Povsic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells
- (2015) Taro Shimizu et al. IMMUNOBIOLOGY
- Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
- (2015) Yu Mima et al. MOLECULAR PHARMACEUTICS
- Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin
- (2015) Giuseppe Toffoli et al. Nanomedicine
- Exosome Delivered Anticancer Drugs Across the Blood-Brain Barrier for Brain Cancer Therapy in Danio Rerio
- (2015) Tianzhi Yang et al. PHARMACEUTICAL RESEARCH
- Anti-PEG immunity: emergence, characteristics, and unaddressed questions
- (2015) Qi Yang et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- New FDA Draft Guidance on Immunogenicity
- (2014) Ashwin Parenky et al. AAPS Journal
- Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
- (2014) Michael S Hershfield et al. ARTHRITIS RESEARCH & THERAPY
- A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
- (2013) Yanhua Tian et al. BIOMATERIALS
- Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity
- (2013) Jessian L Munoz et al. Molecular Therapy-Nucleic Acids
- Questioning the use of PEGylation for drug delivery
- (2013) Johan J. F. Verhoef et al. Drug Delivery and Translational Research
- Exosomes for targeted siRNA delivery across biological barriers
- (2012) Samir EL Andaloussi et al. ADVANCED DRUG DELIVERY REVIEWS
- Intravenous Administration of Polyethylene Glycol-Coated (PEGylated) Proteins and PEGylated Adenovirus Elicits an Anti-PEG Immunoglobulin M Response
- (2012) Taro Shimizu et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
- (2012) Shin-ichiro Ohno et al. MOLECULAR THERAPY
- Maintenance and break of immune tolerance against human factor VIII in a new transgenic hemophilic mouse model
- (2011) P. M. van Helden et al. BLOOD
- 307 HIGH PREVALENCE OF PRE-EXISTING ANTIBODIES AGAINST POLYETHYLENE GLYCOL (PEG) IN HEPATITIS C (HCV) PATIENTS WHICH IS NOT ASSOCIATED WITH IMPAIRED RESPONSE TO PEG-INTERFERON
- (2010) H. Tillmann et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started